These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 18483249

  • 1. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
    van Kilsdonk JW, Wilting RH, Bergers M, van Muijen GN, Schalkwijk J, van Kempen LC, Swart GW.
    Cancer Res; 2008 May 15; 68(10):3671-9. PubMed ID: 18483249
    [Abstract] [Full Text] [Related]

  • 2. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.
    Cancer Res; 2005 Oct 01; 65(19):8801-8. PubMed ID: 16204050
    [Abstract] [Full Text] [Related]

  • 3. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
    Degen WG, van Kempen LC, Gijzen EG, van Groningen JJ, van Kooyk Y, Bloemers HP, Swart GW.
    Am J Pathol; 1998 Mar 01; 152(3):805-13. PubMed ID: 9502422
    [Abstract] [Full Text] [Related]

  • 4. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
    Swart GW, Lunter PC, Kilsdonk JW, Kempen LC.
    Cancer Metastasis Rev; 2005 Jun 01; 24(2):223-36. PubMed ID: 15986133
    [Abstract] [Full Text] [Related]

  • 5. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
    Jezierska A, Matysiak W, Motyl T.
    Med Sci Monit; 2006 Aug 01; 12(8):BR263-73. PubMed ID: 16865058
    [Abstract] [Full Text] [Related]

  • 6. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
    Ikeda K, Quertermous T.
    J Biol Chem; 2004 Dec 31; 279(53):55315-23. PubMed ID: 15496415
    [Abstract] [Full Text] [Related]

  • 7. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
    van Kempen LC, Meier F, Egeblad M, Kersten-Niessen MJ, Garbe C, Weidle UH, Van Muijen GN, Herlyn M, Bloemers HP, Swart GW.
    J Invest Dermatol; 2004 May 31; 122(5):1293-301. PubMed ID: 15140234
    [Abstract] [Full Text] [Related]

  • 8. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
    Hong X, Michalski CW, Kong B, Zhang W, Raggi MC, Sauliunaite D, De Oliveira T, Friess H, Kleeff J.
    J Surg Oncol; 2010 Jun 01; 101(7):564-9. PubMed ID: 20461761
    [Abstract] [Full Text] [Related]

  • 9. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
    van Kilsdonk JW, Takahashi N, Weidle U, Burtscher H, Jarry J, Daha MR, Swart GW, van Kempen LC.
    J Invest Dermatol; 2012 May 01; 132(5):1462-70. PubMed ID: 22318386
    [Abstract] [Full Text] [Related]

  • 10. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
    Uhlenbrock K, Eberth A, Herbrand U, Daryab N, Stege P, Meier F, Friedl P, Collard JG, Ahmadian MR.
    J Cell Sci; 2004 Sep 15; 117(Pt 20):4863-71. PubMed ID: 15340013
    [Abstract] [Full Text] [Related]

  • 11. ALCAM/CD166: cancer-related issues.
    Weidle UH, Eggle D, Klostermann S, Swart GW.
    Cancer Genomics Proteomics; 2010 Sep 15; 7(5):231-43. PubMed ID: 20952758
    [Abstract] [Full Text] [Related]

  • 12. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
    Darvishi B, Boroumandieh S, Majidzadeh-A K, Salehi M, Jafari F, Farahmand L.
    Exp Mol Pathol; 2020 Aug 15; 115():104443. PubMed ID: 32380056
    [Abstract] [Full Text] [Related]

  • 13. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
    Ishiguro F, Murakami H, Mizuno T, Fujii M, Kondo Y, Usami N, Yokoi K, Osada H, Sekido Y.
    J Thorac Oncol; 2012 May 15; 7(5):890-9. PubMed ID: 22722789
    [Abstract] [Full Text] [Related]

  • 14. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.
    Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M, Rosenthal A.
    Prostate; 2003 Jan 01; 54(1):34-43. PubMed ID: 12481253
    [Abstract] [Full Text] [Related]

  • 15. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
    van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW.
    Am J Pathol; 2000 Mar 01; 156(3):769-74. PubMed ID: 10702391
    [Abstract] [Full Text] [Related]

  • 16. Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes.
    Rauch SJ, Rosenkranz AC, Böhm A, Meyer-Kirchrath J, Hohlfeld T, Schrör K, Rauch BH.
    Vascul Pharmacol; 2011 Mar 01; 54(3-6):93-9. PubMed ID: 21440089
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
    Ye M, Du YL, Nie YQ, Zhou ZW, Cao J, Li YF.
    Mol Med Rep; 2015 Mar 01; 11(3):2004-12. PubMed ID: 25395097
    [Abstract] [Full Text] [Related]

  • 18. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
    Swart GW.
    Eur J Cell Biol; 2002 Jun 01; 81(6):313-21. PubMed ID: 12113472
    [Abstract] [Full Text] [Related]

  • 19. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A, All-Ericsson C, Economou MA, Aström K, Axelson M, Seregard S, Larsson O, Girnita L.
    Acta Ophthalmol; 2008 Nov 01; 86 Thesis 4():26-34. PubMed ID: 19032679
    [Abstract] [Full Text] [Related]

  • 20. ALCAM (CD166) is a surface marker for early murine cardiomyocytes.
    Hirata H, Murakami Y, Miyamoto Y, Tosaka M, Inoue K, Nagahashi A, Jakt LM, Asahara T, Iwata H, Sawa Y, Kawamata S.
    Cells Tissues Organs; 2006 Nov 01; 184(3-4):172-80. PubMed ID: 17409743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.